| Accession Number | 0001632901-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Exercise/Conversion | 125 | $208.90 | $26,112.50 | 5,262 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Mar 2, 2026 | Sale | 125 | $492.59 | $61,573.75 | 5,137 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Mar 3, 2026 | Sale | 4,728 | $487.18 | $2,303,387.04 | 409 | Indirect | by Trust | View Details | |
EVP & Chief Medical Officer | Non-Qualified Stock Option (right to buy) | Derivative | Mar 2, 2026 | Exercise/Conversion | 125 | $0.00 | $0.00 | 0 | Direct | โ | View Details |